The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN
The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Abstract
The colicin G producer Escherichia coli CA46, the colicin H producer E. coli CA58 and E. coli Nissle 1917 (DSM 6601) were shown to produce microcin H47 and the newly described microcin M. Both microcins were exported like colicin V by an RND-type export system, including TolC. The gene cluster encoding microcins H47 and M in strains CA46 and CA58 is nearly identical to that in strain DSM 6601, except that two additional genes are included. A Fur box identified in front of the microcin-encoding genes explained the observed iron regulation of microcin production. The catecholate siderophore receptors Fiu, Cir and FepA from E. coli and IroN, Cir and FepA from Salmonella were identified as receptors for microcins M, H47 and E492. IroN takes up the glucose-containing catecholate siderophore salmochelin, whose synthesis is encoded in the iro gene cluster found in Salmonella and certain, often uropathogenic, E. coli strains. A gene in this iro cluster, iroB, which encodes a putative glycosyltransferase, was also found in the microcin H47/M and microcin E492 gene clusters. These microcins could aid the producing strain in competing against enterobacteria that utilize catecholate siderophores.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“having two plasmids (pMUT1 and pMUT2) synthetizing microcins M and H47 (active against Salmonella strains) [26, 31, 32]”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [32]
In the citing paper
“the strain Nissle 1917, besides the already described two microcins, known as M and H47 [31, 32], demonstrates the presence of one colicin and one bottromycin [116], both not phenotypically expressed.”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [32]
In the citing paper
“EcN is believed to impede the growth of opportunistic pathogens, including Salmonella spp. and other coliform enteropathogens, through the production of microcin proteins or production of iron-scavenging siderophores18,22,23.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [22]
Citations
Cites
Experiments in molecular genetics
Miller, J. H. (1972) · Medical Entomology and Zoology · Cited by 27,157
Welch, R. A., Burland, V., Plunkett, G., Redford, P., Roesch, P., Rasko, D., Buckles, E. L., Liou, S.-R., Boutin, A., Hackett, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252529799 · Cited by 1,531 · cited 7×
“coli CFT073 (Welch et al., 2002), in which, however, genes mcmA and mcmI were not annotated (GenBank accesssion number AE016758, bp 273878–284628).”
InfluentialImproved single and multicopy lac-based cloning vectors for protein and operon fusions
Simons, R. W., Houman, F., & Kleckner, N. (1987) · Gene · doi:10.1016/0378-1119(87)90095-3 · Cited by 1,518
Current Protocols in Molecular Biology
(2018) · Current Protocols in Molecular Biology · doi:10.1002/(issn)1934-3647 · Cited by 1,372
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101 · cited 1×
“, 1995), is the active component of the probiotic MutaflorH, which is used for the treatment of various gastrointestinal disturbances and diseases (Kruis et al., 1997; Lodinova-Zadnikova et al., 1998; Malchow, 1997; Rembacken et al., 1999).”
Koronakis, V., Sharff, A., Koronakis, E., Luisi, B., & Hughes, C. (2000) · Nature · doi:10.1038/35016007 · Cited by 1,086 · cited 1×
“The ABC transporter CvaB is connected by CvaA to the trimeric outer-membrane protein TolC, which forms a single bbarrel in the outer membrane with a bundle of a-helices extending into the periplasm ( Koronakis et al., 2000 ).”
Casadaban, M. J., & Cohen, S. N. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4530 · Cited by 924 · cited 1×
“To identify the encoding genes, strain DSM 6601 was mutagenized with the transposing phage Mud1(Amp, lac) (Casadaban & Cohen, 1979).”
MethodKRUIS, W., SCHÜTZ, E., FRIC, P., FIXA, B., JUDMAIER, G., & STOLTE, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 775 · cited 1×
“, 1995), is the active component of the probiotic MutaflorH, which is used for the treatment of various gastrointestinal disturbances and diseases (Kruis et al., 1997; Lodinova-Zadnikova et al., 1998; Malchow, 1997; Rembacken et al., 1999).”
Tseng, T., Gratwick, K. S., Kollman, J. M., Park, D., Nies, D. H., Goffeau, A., & Saier, M. H. (1999) · PubMed · Cited by 729
Havarstein, L. S., Diep, D. B., & Nes, I. F. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02295.x · Cited by 612 · cited 2×
“In addition, CvaB contributes to cleavage of the microcins after a glycine–glycine (or alanine–glycine) motif during export (Havarstein et al ., 1995).”
Research works printed but not linked: 2
- Earhart, 1996, Uptake and metabolism of iron and molybdenum, 1075
- Fredericq, 1948, Actions antibiotiques reciproques chez les Enterobacteriaceae, Rev Belge Pathol Exp Med, 19 suppl 4, 1
Cited by
Items 101–200 of 233
How Bacteria-Induced Apoptosis of Intestinal Epithelial Cells Contributes to Mucosal Inflammation
Hausmann, M. (2010) · International Journal of Inflammation · doi:10.4061/2010/574568 · Cited by 54
Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development
Parker, J. K., & Davies, B. W. (2022) · Microbiology · doi:10.1099/mic.0.001175 · Cited by 56
Effendi, S. S. W., & Ng, I. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2109405 · Cited by 50
“catecholate enterobactin and salmochelin, hydroxamate aerobactin, mixed-type siderophore yersiniabactin, ChuA, and EfeU) against other pathogens (Patzer et al. 2003; Grosse et al. 2006; Valdebenito et al. 2006).”
BackgroundMicrocins and urovirulence in Escherichia coli
Azpiroz, M. F., Poey, M. E., & Laviña, M. D. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.09.003 · Cited by 44
Yu, H., Shang, L., Yang, G., Dai, Z., Zeng, X., & Qiao, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.811378 · Cited by 44
Adediran, J., Leatham-Jensen, M. P., Mokszycki, M. E., Frimodt-Møller, J., Krogfelt, K. A., Kazmierczak, K. M., Kenney, L. J., Conway, T., & Cohen, P. S. (2013) · Infection and Immunity · doi:10.1128/iai.01149-13 · Cited by 46
Hafez, M., Hayes, K., Goldrick, M., Grencis, R. K., & Roberts, I. S. (2010) · Infection and Immunity · doi:10.1128/iai.01406-09 · Cited by 43
“It is known that colonization by Nissle 1917 may lead to an alteration of the hosts’ cytokine repertoire, with increased levels of inteleukin-10 (IL-10), IL12, monocyte chemoattractant protein 1 (MCP-1), MIP2 , and MIP2 (10, 52), together with increased immunoglobulin A secretion (11), lymphocyte or macrophage activat…”
BackgroundMohsin, M., Guenther, S., Schierack, P., Tedin, K., & Wieler, L. H. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.10.003 · Cited by 55
Palmer, J. D., Mortzfeld, B. M., Piattelli, E., Silby, M. W., McCormick, B. A., & Bucci, V. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00302 · Cited by 42
Reitz, Z. L., Sandy, M., & Butler, A. (2017) · Metallomics · doi:10.1039/c7mt00111h · Cited by 44
Escherichia coliNissle 1917 for probiotic use in piglets: evidence for intestinal colonization
Barth, S., Duncker, S., Hempe, J., Breves, G., Baljer, G., & Bauerfeind, R. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04361.x · Cited by 51
“…EcN as a probiotic strain for use in pigs. ª 2009 The Authors Journal compilation ª 2009 The Society for Applied Microbiology, Journal of Applied Microbiology 107 (2009) 1697–1710 1697 directly targeting bacteria in the intestinal lumen (Blum et al. 1995; Patzer et al. 2003; Grozdanov et al. 2004).”
BackgroundThe evolution of spectrum in antibiotics and bacteriocins
Palmer, J. D., & Foster, K. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205407119 · Cited by 46
Zhao, Y., Ding, W., Xu, L., & Sun, J.-Q. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1395477 · Cited by 54
Geldart, K., Forkus, B., McChesney, E., McCue, M., & Kaznessis, Y. N. (2016) · Pharmaceuticals · doi:10.3390/ph9040060 · Cited by 39
Massip, C., & Oswald, É. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00381 · Cited by 39
“Consequently, unlike strain CA46, E. coliCA58 does not produceMccI47 (Patzer, 2003; Poey et al., 2006; Vassiliadis et al., 2010).”
BackgroundMethodInfluentialInvolvement of Enterobactin Synthesis Pathway in Production of Microcin H47
Azpiroz, M. F., & Laviña, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1235-1241.2004 · Cited by 38
“Indeed, microcin E492 as well as the newly described microcin M have recently been reported to employ the catechol uptake pathway for entry into cells ( 17 ).”
BackgroundNon-classical roles of bacterial siderophores in pathogenesis
Arnold, E. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1465719 · Cited by 39
Interplay between siderophores and colibactin genotoxin in Escherichia coli
Martín, P., Tronnet, S., Garcie, C., & Oswald, É. (2017) · IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology · doi:10.1002/iub.1612 · Cited by 33
Barbaro, M. R., Fuschi, D., Cremon, C., Carapelle, M., Dino, P., Marcellini, M. M., Dothel, G., Ponti, F. D., Stanghellini, V., & Barbara, G. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13388 · Cited by 41
Šplíchal, I., Fagerhol, M. K., Trebichavský, I., Šplíchalová, A., & Schulze, J. (2005) · Immunobiology · doi:10.1016/j.imbio.2004.09.009 · Cited by 37
Bacteriocins: antibiotics in the age of the microbiome
Egan, K. M., Ross, R. P., & Hill, C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20160015 · Cited by 40
Carolak, E., Czajkowska, J., Stypułkowska, A., Waszczuk, W., Dutkiewicz, A., & Grzymajło, K. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2519696 · Cited by 42
Soundararajan, M., von Bünau, R., & Oelschlaeger, T. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02783 · Cited by 36
Bacteriocins: Curial guardians of gastrointestinal tract
Gu, Q., Yan, J., Lou, Y., Zhang, Z., Li, Y., Zhu, Z., Liu, M., Wu, D., Liang, Y., Pu, J., et al. (2024) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13292 · Cited by 32
Schinner, S., Mokszycki, M. E., Adediran, J., Leatham-Jensen, M. P., Conway, T., & Cohen, P. S. (2015) · Infection and Immunity · doi:10.1128/iai.02943-14 · Cited by 31
Engineered probiotics: a new era in treating inflammatory bowel disease
Duan, S., Wang, Y., Zhan, S., Ye, Z., Luo, T., Zhou, Y., Xu, H., & Huang, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07271-y · Cited by 33
Šmajs, D., Strouhal, M., Matějková, P., Čejková, D., Cursino, L., Chartone‐Souza, E., Šmarda, J., & Nascimento, A. M. A. (2008) · Plasmid · doi:10.1016/j.plasmid.2007.08.002 · Cited by 28
Sibinelli‐Sousa, S., Silva, A. L. D. A., Hespanhol, J. T., & Bayer‐Santos, E. (2021) · FEBS Journal · doi:10.1111/febs.16211 · Cited by 31
Šmajs, D., Bureš, J., Šmarda, J., Chaloupková, E., Kvetina, J., Förstl, M., Kohoutová, D., Kuneš, M., Rejchrt, S., Lesná, J., et al. (2011) · Current Microbiology · doi:10.1007/s00284-011-0051-x · Cited by 27
Rationale for probiotic treatment strategies in inflammatory bowel disease
Schultz, M., & Lindström, A. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.3.337 · Cited by 30
Ohno, M., Hasegawa, M., Hayashi, A., Caballero-Flores, G. G., Alteri, C. J., Lawley, T. D., Kamada, N., Núñez, G., & Inohara, N. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008928 · Cited by 26
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
Kirundi, J., Moghadamrad, S., & Urbaniak, C. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i11.1651 · Cited by 26
“…produce toxic antimicrobial peptides through their type 6 secretion systems (T6SS)[16], E. coli produces narrow-spectrum antibiotics called microcins that effectively kill competitors within their niche[17,18], and the probiotic Bifidobacterium secretes broad-spectrum bacteriocins[19].”
The Potential of Bacteriocin-Producing Probiotics and Associated Caveats
Gordon, D. M. (2009) · Future Microbiology · doi:10.2217/fmb.09.78 · Cited by 24
Micenková, L., Frankovičová, L., Jaborníková, I., Bosák, J., Dítě, P., Šmarda, J., Vrba, M., Ševčíková, A., Kmetova, M., & Šmajs, D. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.04.008 · Cited by 25
Zhang, P., Ye, Z., Ye, C., Zou, H., Gao, Z., & Pan, J. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103808 · Cited by 25
Hrala, M., Bosák, J., Micenková, L., Křenová, J., Lexa, M., Pirková, V., Tomáštíková, Z., Koláčková, I., & Šmajs, D. (2021) · Applied and Environmental Microbiology · doi:10.1128/aem.03121-20 · Cited by 26
Microcin PDI regulation and proteolytic cleavage are unique among known microcins
Zhao, Z., Orfe, L. H., Liu, J., Lu, S.-Y., Besser, T. E., & Call, D. R. (2017) · Scientific Reports · doi:10.1038/srep42529 · Cited by 23
Geervliet, M., de Vries, H., Jansen, C. A., Rutten, V. P. M. G., van Hees, H. M. J., Wen, C., Skovgaard, K., Antonello, G., Savelkoul, H. F. J., Smidt, H., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.842437 · Cited by 24
Blay, G. L., Hammami, R., Lacroix, C., & Fliss, I. (2012) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-012-9111-1 · Cited by 28
The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
Bury, S., Soundararajan, M., Bharti, R., von Bünau, R., Förstner, K. U., & Oelschlaeger, T. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00929 · Cited by 21
“…Source E. coli Nissle 1917 (EcN) O6:K5:H1 Non-pathogenic probiotic strain Ardeypharm, Herdecke SK22D O6:K5:H1 Microcin deletion mutant of EcN Patzer et al., 2003 SE15 O150:H5 Commensal strain Japan Collection of Microorganisms (JCM) IAI1 O8: K- Commensal strain Erick Denamur, University…”
BackgroundMethodInfluentialSchumann, S., Alpert, C., Engst, W., Loh, G., & Blaut, M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07340-11 · Cited by 20
Marcoleta, A. E., Gutiérrez-Cortez, S., Hurtado, F., Argandoña, Y., Corsini, G., Monasterio, O., & Lagos, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200835 · Cited by 19
Human microbiota peptides: important roles in human health
Shah, A. B., & Shim, S. H. (2025) · Natural Product Reports · doi:10.1039/d4np00042k · Cited by 26
Evidence for Widespread Class II Microcins in Enterobacterales Genomes
Cole, T. J., Parker, J. K., Feller, A. L., Wilke, C. O., & Davies, B. W. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01486-22 · Cited by 23
Seco, E. M., & Fernández, L. Á. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13967 · Cited by 24
Bacteriocinogeny in experimental pigs treated with indomethacin andEscherichia coli Nissle
Bureš, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.609 · Cited by 18
Exploring the bioactive landscape: peptides and non-peptides from the human microbiota
Shah, A. B., Cho, H., & Shim, S. H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00713-x · Cited by 21
Transition metals and host-microbe interactions in the inflamed intestine
Zhu, W., Spiga, L., & Winter, S. (2019) · BioMetals · doi:10.1007/s10534-019-00182-8 · Cited by 17
“…IroN (S. Typhimurium) Baumler et al. (1998) Dihydroxybenzoate CirA (E. coli) Fiu (E. coli) Cardelli and Konisky (1974), Hantke (1990) Ferrichrome FhuA (S. Typhimurium) Tsolis et al. (1995) Bifidobacterium Lactoferrin Unknown Oda et al. (2014), Petschow and Talbott (1991) (Patzer et al. 2003).”
Bosák, J., Laiblová, P., Šmarda, J., Dědičová, D., & Šmajs, D. (2012) · Journal of Bacteriology · doi:10.1128/jb.05885-11 · Cited by 17
The Production In Vivo of Microcin E492 with Antibacterial Activity Depends on Salmochelin and EntF
Mercado, G., Tello, M., Marín, M., Monasterio, O., & Lagos, R. (2008) · Journal of Bacteriology · doi:10.1128/jb.00351-08 · Cited by 17
Micenková, L., Šišková, P., Bosák, J., Jamborová, I., Černohorská, L., & Šmajs, D. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0013 · Cited by 16
Ma, Y., Fu, W., Hong, B., Wang, X., Jiang, S., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411688 · Cited by 17
Delavy, M., Sertour, N., d’Enfert, C., & Bougnoux, M. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.08.002 · Cited by 16
Zhao, Z., Eberhart, L. J., Orfe, L. H., Lu, S.-Y., Besser, T. E., & Call, D. R. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.01704-15 · Cited by 16
Mazurek-Popczyk, J., Pisarska, J., Bok, E., & Baldy-Chudzik, K. (2020) · Antibiotics · doi:10.3390/antibiotics9070411 · Cited by 18
Singh, S., & Koo, O. K. (2024) · Pathogens · doi:10.3390/pathogens13080642 · Cited by 19
“…peptides called microcins M and H47, which are absorbed by salmochelin uptake After the salmochelin uptake systems absorb the salmochelin derivatives conjugated to antimicrobial peptides, they can effectively target and inhibit the growth of Salmonella bacteria in the gut. systems [25,26].”
Biological control of human digestive microbiota using antimicrobial cultures and bacteriocins
Fliss, I., Hammami, R., & Lay, C. (2011) · Elsevier eBooks · doi:10.1533/9780857090522.2.240 · Cited by 22
Vassiliadis, G., Destoumieux‐Garzón, D., & Péduzzi, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7692-5_16 · Cited by 19
“In Salmonella, class IIb microcins would use IroN , FepA and Cir receptors (Patzer et al., 2003).”
BackgroundInfluentialA Putative Microcin Amplifies Shiga Toxin 2a Production of Escherichia coli O157:H7
Figler, H. M., Xiaoli, L., Banerjee, K., Hoffmann, M., Yao, K., & Dudley, E. G. (2019) · Journal of Bacteriology · doi:10.1128/jb.00353-19 · Cited by 17
Bisaro, F., Shuman, H. A., Feldman, M. F., Gebhardt, M. J., & Pukatzki, S. U. (2023) · Microbiology · doi:10.1099/mic.0.001346 · Cited by 14
“Microcin production is toxic to the producing bacterial cells and to kin cells if self-immunity strategies are not available [13, 15, 27, 38, 63, 64].”
InfluentialCherrak, Y., Younes, A. A., Perez‐Molphe‐Montoya, E., Maurer, L., Yilmaz, K., Enz, U., Zeder, C., Kiefer, P., Christen, P., Gül, E., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.02.004 · Cited by 14
Thomas, S., Suryaletha, K., Savithri, A. V., Nayar, S. A., Asokan, S., & Rajeswary, D. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203724666221019111515 · Cited by 15
Šmajs, D., Čejková, D., Micenková, L., Lima-Bittencourt, C. I., Chartone‐Souza, E., Šmarda, J., & Nascimento, A. M. A. (2012) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2012.00365.x · Cited by 12
Schulz, M., Gaitanoglou, V., Mantel, O., Hövelmann, Y., Hübner, F., Dobrindt, U., & Humpf, H. (2020) · Metabolites · doi:10.3390/metabo10060221 · Cited by 12
Petersen, A. M., Schjørring, S., Gerstrøm, S. C., & Krogfelt, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022823 · Cited by 11
“Nissle's probiotic abilities are presumably linked to its ability to prevent colonization of the gut with pathogenic microorganisms by producing two microcins and being able to produce a strong biofilm”
BackgroundZídek, Z., Kmoníčková, E., Kostecká, P., & Tlaskalová‐Hogenová, H. (2010) · Folia Microbiologica · doi:10.1007/s12223-010-0027-4 · Cited by 13
Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens
Mortzfeld, B. M., Bhattarai, S. K., & Bucci, V. (2024) · eLife · doi:10.7554/elife.102912 · Cited by 12
“…other bacteria, particularly in resource-scarce environments such as the gastrointestinal tract ( Vassiliadis et al., 2010 ; Palmer et al., 2020 ; Patzer et al., 2003 ) and are often associated with increased pathogenicity or virulence ( Miethke and Marahiel, 2007 ; Wilson et al., 2016 ;…”
Antibacterial microcins are ubiquitous and functionally diverse across bacterial communities
Parker, J. K., Feller, A. L., Gu, R., Sanchez-Paiva, S., Perez, B. C., O’Donnell, A. C., Deng, W., Ousterhout, R. M., Kim, S., Wilke, C. O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61151-z · Cited by 14
Class IIb Microcin MccM Interferes with Oxidative Phosphorylation in Escherichia coli
Wang, K.-K. A., Singh, J., Albin, J. S., Pentelute, B. L., & Nolan, E. M. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00226 · Cited by 12
Semantic search using protein large language models detects class II microcins in bacterial genomes
Kulikova, A. V., Parker, J. K., Davies, B. W., & Wilke, C. O. (2024) · mSystems · doi:10.1128/msystems.01044-24 · Cited by 10
Ye, Z., Tan, Q., Woltemate, S., Tan, X., Römermann, D., Graßl, G. A., Vital, M., Seidler, U. E., & Kini, A. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae294 · Cited by 15
“33,34 While EcN has demonstrated its ability to produce SCFA in vitro, 31 there is a lack of reports on its in vivo capabilities.”
An Insight into Bacteriocins for Combating Microbial Infections and Ensuring Food Safety
Howlader, M., Das, S. C., Gupta, S. D., Barman, D. N., Islam, M. M., Mia, M. E., Salahuddin, M., & Hossain, M. M. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10691-5 · Cited by 11
Štaudová, B., Micenková, L., Bosák, J., Hrazdilová, K., Slaninková, E., Vrba, M., Ševčíková, A., Kohoutová, D., Woznicová, V., Bureš, J., et al. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0530-5 · Cited by 12
Wang, B., BingFen, H., Chen, J., Li, W., Yang, L., Yao, L., & Niu, Q. (2019) · Molecular Biology Reports · doi:10.1007/s11033-018-04574-w · Cited by 10
Bosák, J., Micenková, L., Vrba, M., Ševčíková, A., Dědičová, D., Garzetti, D., & Šmajs, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081829 · Cited by 9
Conover, M. S., Hibbing, M. E., & Hultgren, S. J. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_52 · Cited by 10
Heparin stimulates biofilm formation of Escherichia coli strain Nissle 1917
Wu, D., Li, X., Yu, Y., Gong, B., & Zhou, X. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-03019-4 · Cited by 10
Jirillo, E., Palmirotta, R., Colella, M., & Santacroce, L. (2024) · Pathophysiology · doi:10.3390/pathophysiology31010005 · Cited by 9
“The insertion of microcin H47 and microcin M into E. coli Nissle 1917 enhanced their activity against UPEC strains [151,152].”
BackgroundSchultz, M., & Burton, J. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00005-7 · Cited by 12
Mokszycki, M. E., Leatham-Jensen, M. P., Steffensen, J. L., Zhang, Y., Krogfelt, K. A., Caldwell, M. E., Conway, T., & Cohen, P. S. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02166-18 · Cited by 9
Dezfulian, H., Tremblay, D., & Harel, J. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09773.x · Cited by 8
Rebai, Y., Wagner, L., Gnaien, M., Hammer, M. L., Kapitan, M., Niemiec, M. J., Mami, W., Mosbah, A., Messadi, E., Mardassi, H., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11081929 · Cited by 8
Fang, C.-M., Wang, J. Y., Chinchilla, M., Levine, M. M., Blackwelder, W. C., & Galen, J. E. (2008) · Infection and Immunity · doi:10.1128/iai.00487-08 · Cited by 7
“4 CVD 1208S CVD 1208S GFPuv 0 (30) 0 (31) 0 (41) 80 (4,088) 100 (19,810) 5 CVD 1208S(pGEN222) CVD 1208S(pGEN222) GFPuv 100 (46,051) 100 (50,720) 100 (914,116) 100 (1,189,972) 100 (1,390,420) 6 CVD 1208S(pGEN222I) CVD 1208S(pGEN222I) GFPuv 100 (85,244) 100 (74,695) 100 (995,557) 100 (1,125,476) 100 (1,207,469)”
BackgroundDi Pierro, F., Sagheddu, V., Galletti, S., Casaroli, A., Labrini, E., Soldi, S., Cazzaniga, M., Bertuccioli, A., Matera, M., Cavecchia, I., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10522-5 · Cited by 5
“As regards to bacteriocin genes, the strain Nissle 1917, besides the already described two microcins, known as M and H47 [31, 32], demonstrates the presence of one colicin and one bottromycin [116], both not pheno-typically expressed.”
Alhubail, M., McBain, A. J., & O’Neill, C. A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00347-24 · Cited by 8
“However, the mechanism may also involve other effects such as interference with pathogen internalization which is a reported activity of E. coli Nissle against intestinal pathogens (43).”
BackgroundSnell, C. B., Winston, J. A., Quimby, J. M., Diaz-Campos, D. V., Gibson, J. F., Harrison, A., Byron, J. K., Justice, S. S., & Rudinsky, A. J. (2022) · American Journal of Veterinary Research · doi:10.2460/ajvr.21.07.0096 · Cited by 5
Efficacy of different treatments available against bacterial pathogens in fish
Hajam, Y. A., Kumar, R., Rani, R., Sharma, P., & Diksha, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85624-9.00013-0 · Cited by 5
Sequence analysis of the plasmid pColG from the Escherichia coli strain CA46
Avguštin, J. A., & Grabnar, M. (2006) · Plasmid · doi:10.1016/j.plasmid.2006.05.010 · Cited by 5
Looking into key bacterial proteins involved in gut dysbiosis
Zeng, X.-Y., & Li, M. (2021) · World Journal of Methodology · doi:10.5662/wjm.v11.i4.130 · Cited by 4
Reiss, D. J., Engstrom, M. D., & Mobley, H. L. T. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_101 · Cited by 4
Transcription Factor‐Based Biosensors and Their Application in Microbiome Engineering
Kim, S. K., Woo, S. G., Kim, T. H., Park, S. H., Lee, J. J., Park, A.-H., Oh, S. H., Bak, S. K., Lee, S., & Lee, D. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch10 · Cited by 5
Emergence of antibiotic resistance in gut microbiota and its effect on human health
Kumar, M., Sharma, A., Verma, A., & Shrivastava, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00002-7 · Cited by 4
Prabhu, C. P., Kotian, A., Aditya, V., & Deekshit, V. K. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00196-25 · Cited by 5
Dezfulian, A., Ardekani, A. M. Z., Aslani, M. M., Dabiri, H., & Zali, M. R. (2008) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v1i3.32 · Cited by 4
Geervliet, M. (2021) · doi:10.18174/553257 · Cited by 2
Kuneš, M., & Kvetina, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00056-5 · Cited by 5
Inhibition of Listeria Monocytogenes by Human Gut Bacteria
Olesky, P. S. (2018) · Cited by 2
Deep characterization of Escherichia coli in a cohort of mothers and their infants
de Muinck, & Jacques, É. (2013) · Cited by 2
A Genomic View of Escherichia Coli Diversity from Dairy Calves
Fossen, J. (2019) · Minds at UW (University of Wisconsin) · Cited by 2
Ma, M. (2019) · UA Campus Repository (The University of Arizona) · Cited by 2
Metadata
- Authors
- Patzer, S. I., Baquero, M. R., Bravo, D., Moreno, F., & Hantke, K.
- Affiliations
- University of Tübingen (DE)
- Hospital Universitario Ramón y Cajal (ES)
- Venue
- Microbiology
- Publisher
- Microbiology Society
- Published
- 2003-09-01
- Volume
- 149
- Issue
- 9
- Pages
- 2557-2570
- ISSN
- 1350-0872 (ISSN-L)
- 1465-2080
- OpenAlex
- W2155235701
- Cited by
- 233
- References
- 61
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 13 · 2023: 5 · 2022: 19 · 2021: 10 · 2020: 16 · 2019: 15 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 5 · 2014: 10 · 2013: 9 · 2012: 8
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds der Chemischen Industrie
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- microcin E492, catecholate siderophores, siderophore receptors, FepA, CIR, iron, TolC, Fur box, iron regulation, gene clusters, Escherichia coli, Salmonella
- MeSH terms
- Bacterial Outer Membrane Proteins, Carrier Proteins, Colicins, Escherichia coli, Multigene Family, Molecular Sequence Data, Peptides, Receptors, Cell Surface, Genome, Bacterial, Antimicrobial Cationic Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.